HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Flavonoid derivative 7,8-DHF attenuates TBI pathology via TrkB activation.

Abstract
Traumatic brain injury (TBI) is followed by a state of metabolic dysfunction, affecting the ability of neurons to use energy and support brain plasticity; there is no effective therapy to counteract the TBI pathology. Brain-derived neurotrophic factor (BDNF) has an exceptional capacity to support metabolism and plasticity, which highly contrasts with its poor pharmacological profile. We evaluated the action of a flavonoid derivative 7,8-dihydroxyflavone (7,8-DHF), a BDNF receptor (TrkB) agonist with the pharmacological profile congruent for potential human therapies. Treatment with 7,8-DHF (5mg/kg, ip, daily for 7 days) was effective to ameliorate the effects of TBI on plasticity markers (CREB phosphorylation, GAP-43 and syntaxin-3 levels) and memory function in Barnes maze test. Treatment with 7,8-DHF restored the decrease in protein and phenotypic expression of TrkB phosphorylation after TBI. In turn, intrahippocampal injections of K252a, a TrkB antagonist, counteracted the 7,8-DHF induced TrkB signaling activation and memory improvement in TBI, suggesting the pivotal role of TrkB signaling in cognitive performance after brain injury. A potential action of 7,8-DHF on cell energy homeostasis was corroborated by the normalization in levels of PGC-1α, TFAM, COII, AMPK and SIRT1 in animals subjected to TBI. Results suggest a potential mechanism by which 7,8-DHF counteracts TBI pathology via activation of the TrkB receptor and engaging the interplay between cell energy management and synaptic plasticity. Since metabolic dysfunction is an important risk factor for the development of neurological and psychiatric disorders, these results set a precedent for the therapeutic use of 7,8-DHF in a larger context.
AuthorsRahul Agrawal, Emily Noble, Ethika Tyagi, Yumei Zhuang, Zhe Ying, Fernando Gomez-Pinilla
JournalBiochimica et biophysica acta (Biochim Biophys Acta) Vol. 1852 Issue 5 Pg. 862-72 (May 2015) ISSN: 0006-3002 [Print] Netherlands
PMID25661191 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2015 Elsevier B.V. All rights reserved.
Chemical References
  • 6,7-dihydroxyflavone
  • Carbazoles
  • Cyclic AMP Response Element-Binding Protein
  • Flavones
  • GAP-43 Protein
  • Indole Alkaloids
  • Qa-SNARE Proteins
  • staurosporine aglycone
  • Receptor, trkB
Topics
  • Animals
  • Brain Injuries (metabolism, physiopathology, prevention & control)
  • Carbazoles (pharmacology)
  • Cognition Disorders (metabolism, physiopathology, prevention & control)
  • Cyclic AMP Response Element-Binding Protein (metabolism)
  • Energy Metabolism (drug effects)
  • Flavones (pharmacology)
  • GAP-43 Protein (metabolism)
  • Immunoblotting
  • Indole Alkaloids (pharmacology)
  • Male
  • Maze Learning (drug effects)
  • Memory (drug effects)
  • Microscopy, Fluorescence
  • Mitochondria (drug effects, metabolism)
  • Phosphorylation (drug effects)
  • Qa-SNARE Proteins (metabolism)
  • Rats, Sprague-Dawley
  • Receptor, trkB (agonists, antagonists & inhibitors, metabolism)
  • Signal Transduction (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: